October 08, 2019
A California federal judge on Monday appointed Levi & Korsinsky LLP to lead a proposed class action alleging Corcept Therapeutics Inc. hid that it bribed doctors to promote its mifepristone drug Korlym and engaged in other shady sales practices, causing its stock to plummet when the allegations came to light.